周 琪,賀現(xiàn)輝,陽(yáng)巧梅,馮賽祥,樊惠英*,廖 明*
(1.華南農(nóng)業(yè)大學(xué)獸醫(yī)學(xué)院,廣州 510642;2.邵陽(yáng)職業(yè)技術(shù)學(xué)院,邵陽(yáng) 422000)
?
副豬嗜血桿菌SC096株莢膜多糖抗豬肺泡巨噬細(xì)胞吞噬能力的研究
周琪1,賀現(xiàn)輝1,陽(yáng)巧梅2,馮賽祥1,樊惠英1*,廖明1*
(1.華南農(nóng)業(yè)大學(xué)獸醫(yī)學(xué)院,廣州 510642;2.邵陽(yáng)職業(yè)技術(shù)學(xué)院,邵陽(yáng) 422000)
為探討莢膜多糖在副豬嗜血桿菌(Haemophilusparasuis)抗豬肺泡巨噬細(xì)胞吞噬中的作用,作者用間接免疫熒光試驗(yàn)和流式細(xì)胞術(shù)對(duì)H.parasuisSC096分離株及其莢膜缺陷型菌株進(jìn)行了抗巨噬細(xì)胞吞噬試驗(yàn)。間接免疫熒光試驗(yàn)顯示野生菌株組的H.parasuis大多數(shù)存在于巨噬細(xì)胞外,而莢膜多糖缺失突變體則主要存在于巨噬細(xì)胞內(nèi)。流式細(xì)胞儀檢測(cè)結(jié)果表明,對(duì)應(yīng)的野生型菌株組巨噬細(xì)胞總的吞噬率為12.51%,吞入效率為89.61%;而莢膜多糖缺陷型組巨噬細(xì)胞總的吞噬率為27.18%,吞入效率為91.06%。加入外源莢膜多糖后,野生型菌株組巨噬細(xì)胞總的吞噬率降為2.72%,吞入效率降為32.72%;莢膜多糖缺陷型組巨噬細(xì)胞總的吞噬率降為3.59%,吞入效率基本不變,為91.36%。莢膜多糖缺失后H.parasuis抗巨噬細(xì)胞吞噬能力降低,表明H.parasuisSC096株莢膜多糖具有抑制巨噬細(xì)胞吞噬能力的作用。
副豬嗜血桿菌;莢膜多糖;豬肺泡巨噬細(xì)胞;吞噬能力
副豬嗜血桿菌(Haemophilusparasuis)是豬上呼吸道的一種共棲菌,可在特定的條件下入侵機(jī)體而引起嚴(yán)重的全身性疾病[1]。一般認(rèn)為該病的暴發(fā)與豬群的運(yùn)輸?shù)葢?yīng)激因素和免疫狀況有著重要關(guān)系[2]。研究發(fā)現(xiàn)莢膜對(duì)其致病過(guò)程起著重要作用,H.parasuis分為有莢膜菌株和無(wú)莢膜菌株,T.Morozumi等通過(guò)十六烷基三甲基溴化銨沉淀和莢膜染色等方法鑒定了H.parasuis的莢膜結(jié)構(gòu),有莢膜菌株一般是球桿菌樣,而不是通常的棒狀或絲狀,從健康豬上鼻腔分離的H.parasuis菌株多數(shù)具有莢膜,而分離自患病豬的感染的實(shí)質(zhì)性器官等部位的H.parasuis菌株卻只有少數(shù)具有莢膜[3]。有研究表明從健康豬鼻腔中分離的H.parasuis不能有效逃避肺巨噬細(xì)胞的吞噬作用,而在發(fā)病臟器中分離的副豬嗜血桿菌逃避肺巨噬細(xì)胞吞噬的能力更強(qiáng)。同時(shí),在和肺泡巨噬細(xì)胞作用之后體外傳代丟失的莢膜結(jié)構(gòu)可以恢復(fù),這暗示了這種莢膜結(jié)構(gòu)可能使副豬嗜血桿菌更有效地逃避肺巨噬細(xì)胞的吞噬,但具體的抗吞噬機(jī)制還需要進(jìn)一步的研究[4]。莢膜多糖(CPS)對(duì)巨噬細(xì)胞吞噬作用的影響機(jī)制尚不明確。目前已知細(xì)胞松弛素B會(huì)影響巨噬細(xì)胞的吞噬作用,細(xì)胞松弛素B通過(guò)降解細(xì)胞的微絲來(lái)阻斷吞噬泡的形成,從而抑制細(xì)胞的吞噬[5]。
因此,本研究利用H.parasuisSC096分離株及其莢膜多糖缺陷型菌株和純化的莢膜多糖及細(xì)胞松弛素B分別進(jìn)行抗巨噬細(xì)胞吞噬試驗(yàn),用間接免疫熒光試驗(yàn)和流式細(xì)胞術(shù)檢測(cè)巨噬細(xì)胞的吞噬效率,研究莢膜多糖對(duì)H.parasuis抗巨噬細(xì)胞吞噬能力的影響,鑒定H.parasuis莢膜多糖功能,為進(jìn)一步開(kāi)展H.parasuis致病機(jī)制研究提供理論基礎(chǔ)。
1.1菌株與細(xì)胞
副豬嗜血桿菌SC096分離株及其莢膜多糖缺陷型菌株由華南農(nóng)業(yè)大學(xué)農(nóng)業(yè)部獸用疫苗創(chuàng)制重點(diǎn)實(shí)驗(yàn)室保存。豬肺泡巨噬細(xì)胞(PAMs)購(gòu)自美國(guó)ATCC(細(xì)胞編號(hào)CRL-2845)。
1.2主要儀器與試劑
流式細(xì)胞儀(貝克曼公司,美國(guó)),顯微鏡(奧林巴斯CX311,日本),超聲波破碎儀(寧波新芝生物科技股份有限公司 JY96-IIn);TSA(胰蛋白胨大豆瓊脂)、TSB(胰蛋白胨大豆肉湯)和LB培養(yǎng)基為青島海博試劑有限公司產(chǎn)品;細(xì)胞膜紅色熒光探針 (DiI)為碧云天生物技術(shù)研究所產(chǎn)品;預(yù)染蛋白質(zhì)Marker PageRulerTMPrestained Protein Ladder SM0671為加拿大 Fermentas公司產(chǎn)品。試驗(yàn)所用抗體見(jiàn)表1。
表1試驗(yàn)所用抗體
Table 1Antibodys used in this study
名稱Name宿主Host來(lái)源SourceH.parasuisSC096capsularpolysaccharidedeficientstrainPolyclonalAntibodyRabbitOurlaboratoryBovineserumalbuminPolyclonalAntibodyMouseMillipore,USAMouseIgGPolyclonalAntibodylinkedFITCGoatMillipore,USARabbitIgGPolyclonalAntibodylinkedFITCGoatMillipore,USAMouseIgGPolyclonalAntibodylinkedPIGoatMillipore,USARabbitIgGPolyclonalAntibodylinkedPIGoatMillipore,USA
1.3細(xì)菌及細(xì)胞培養(yǎng)
副豬嗜血桿菌在TSA上復(fù)蘇,取單菌落接種于TSB中培養(yǎng)12 h作為種子液,將上述種子液按照1%比例接種于新鮮TSB中,37 ℃,180 r·min-1振蕩培養(yǎng)。將PAMs細(xì)胞(CRL-2845)解凍后轉(zhuǎn)移至75 cm2細(xì)胞瓶,置于5% CO2培養(yǎng)箱37 ℃培養(yǎng)。待細(xì)胞長(zhǎng)滿時(shí)傳代,按1∶2的比例擴(kuò)增細(xì)胞。
1.4間接免疫熒光檢測(cè)H.parasuis抗巨噬細(xì)胞吞噬試驗(yàn)
將細(xì)胞傳至12孔培養(yǎng)板中,加入細(xì)胞膜紅色熒光探針 (DiI)。待細(xì)胞長(zhǎng)至對(duì)數(shù)期(約4.0×105·孔-1)時(shí),分別加入FITC染色的H.parasuisSC096株野生型和莢膜多糖缺陷型菌株(約1.0×107CFU·孔-1),37 ℃孵育1 h,再用無(wú)菌預(yù)冷PBS洗5遍,洗去未被吞噬的細(xì)菌。每個(gè)樣品均有重復(fù)孔,試驗(yàn)重復(fù)3次。然后用pH 7.4的PBST清洗細(xì)胞3遍,4%多聚甲醛固定20 min。PBST洗滌3次,每次5 min,0.25% Triton X-100作用30 min。PBST洗滌3次,每次5 min,滴加5%脫脂奶粉封閉1 h或者4 ℃過(guò)夜。PBST洗滌3次,每次5 min,分別滴加抗相應(yīng)H.parasuis菌株的一抗,37 ℃濕盒作用1 h或者4 ℃過(guò)夜。PBST洗滌3次,每次5 min,滴加稀釋的FITC標(biāo)記的熒光抗兔二抗,室溫作用1 h。PBST洗滌3次,每次5 min,熒光顯微鏡觀察。
1.5流式細(xì)胞術(shù)檢測(cè)H.parasuis抗巨噬細(xì)胞吞噬試驗(yàn)
1.5.1莢膜多糖(CPS)提取及純化將培養(yǎng)好的細(xì)菌用PBS洗兩遍,離心。將細(xì)菌團(tuán)用60 ℃水飽和酚進(jìn)行萃取[6]。30 min后,所得到的苯酚和水相合并,并用蒸餾水透析以除去苯酚。透析液通過(guò)離心澄清并濃縮,冷凍干燥。粗制劑在緩沖液(10 mmol·L-1pH為7.5的Tris-HCl,1 mmol·L-1的氯化鎂,1 mmol·L-1的氯化鈣,50 μg·mL-1核糖核酸酶A和50 μg·mL-1DNA酶Ⅰ)中37 ℃振蕩溫育3 h,加入蛋白酶K 50 μg·mL-160 ℃消化3 h,離心取上清。CPS 100 000 g 離心6 h后,將凝膠樣CPS團(tuán)塊重懸于無(wú)熱原水,凍干。從粗品CPS中去除LPS污染物:將樣品以5 mg·mL-1濃度溶解于2%乙酸,100 ℃孵育2 h。經(jīng)水解的樣品冷卻至室溫,通過(guò)離心澄清將上清液小心地取出并再次透析。將透析后液體冷凍干燥濃縮,凍干的樣品以20 mg·mL-1溶解于PBS中,并過(guò)濾滅菌。純化的CPS進(jìn)行SDS-PAGE并銀染。
1.5.2細(xì)胞的處理參考A.Olvera等的報(bào)道[4],將H.parasuisSC096株野生型和莢膜多糖缺陷型菌株與熒光染料FITC孵育1 h著色,洗去多余染料。將細(xì)胞傳至12孔細(xì)胞培養(yǎng)板中,待細(xì)胞長(zhǎng)至對(duì)數(shù)生長(zhǎng)期(約4.0×105·孔-1)時(shí),分別加入FITC 染色的H.parasuisSC096 株野生型和莢膜多糖缺陷型菌株(約1.0×107CFU·孔-1),另一組同時(shí)加入30 μg提純的莢膜多糖(另設(shè)不加莢膜多糖,而是加細(xì)胞松馳素B的對(duì)照),放回培養(yǎng)箱孵育1 h后,用無(wú)菌預(yù)冷PBS洗5遍,洗去未被吞噬的細(xì)菌。每個(gè)樣品均設(shè)重復(fù)孔,試驗(yàn)重復(fù)3次。
1.5.3流式細(xì)胞術(shù)冰上小心刮取細(xì)胞,輕輕將細(xì)胞懸液轉(zhuǎn)移到5 mL離心管中,800 g離心5 min收集細(xì)胞,用2 mL預(yù)冷PBS洗滌細(xì)胞一次,800 g離心5 min。用2 mL 4%多聚甲醛室溫固定細(xì)胞40 min,800 g離心5 min;2 mL PBS重懸細(xì)胞,800 g離心5 min;用1 mL含0.2% Triton-X100和5% 血清的PBS重懸細(xì)胞,冰上放置10 min,800 g離心5 min。分別加入H.parasuisSC096 株野生型和莢膜多糖缺陷型菌株抗體,冰上放置40 min,800 g離心5 min,用2 mL冷的PBS 重懸細(xì)胞,800 g離心5 min,洗去未結(jié)合一抗,重復(fù)一次。加入熒光標(biāo)記(PI)的二抗,冰上避光放置40 min后,800 g離心5 min,去上清,PBS洗滌兩次。加入0.5 mL 1%多聚甲醛重懸細(xì)胞;流式細(xì)胞儀檢測(cè)。
2.1間接免疫熒光檢測(cè)副豬嗜血桿菌SC096株抗巨噬細(xì)胞吞噬試驗(yàn)
間接免疫熒光結(jié)果顯示,H.parasuisSC096野生型菌株和肺泡巨噬細(xì)胞孵育后,抗吞噬能力較強(qiáng),細(xì)菌(綠色)多分布在巨噬細(xì)胞細(xì)胞膜(棕紅色環(huán))區(qū)域之外(圖1A,白色箭頭所示處);而莢膜多糖缺陷型菌株抗吞噬能力較弱,細(xì)菌(綠色)多分布在巨噬細(xì)胞細(xì)胞膜(棕紅色環(huán))區(qū)域之內(nèi)(圖1B,白色箭頭所示處)。
2.2流式細(xì)胞術(shù)檢測(cè)副豬嗜血桿菌SC096株抗巨噬細(xì)胞吞噬試驗(yàn)2.2.1莢膜多糖的提取SDS-PAGE銀染結(jié)果顯示,提取的H.parasuisSC096株莢膜多糖在35 ku處有一個(gè)清晰的條帶,泳道背景清晰,無(wú)其他雜帶(圖2,泳道1),脂多糖對(duì)照條帶出現(xiàn)在15~25 ku,條帶清晰,泳道背景清晰,無(wú)其他雜帶(圖2,泳道2)。
A.野生型菌株抗巨噬細(xì)胞吞噬,綠色為細(xì)菌,棕紅色環(huán)為巨噬細(xì)胞細(xì)胞膜,細(xì)菌多在細(xì)胞膜外,見(jiàn)白色箭頭所示;B.莢膜多糖缺陷型菌株抗巨噬細(xì)胞吞噬,綠色為細(xì)菌,棕紅色環(huán)為巨噬細(xì)胞細(xì)胞膜,細(xì)菌多在細(xì)胞膜內(nèi),見(jiàn)白色箭頭所示A.Wild-type strain inhibit phagocytosis of macrophages,bacteria are stained green,the cell membrane of macrophages are stained red in circle shape,and most bacteria located outside the membrane (white arrow);B.Capsular polysaccharide-deficient strain anti-macrophage phagocytosis,bacteria are stained green,the cell membrane of macrophages are stained red in circle shape,and most bacteria located inside the membrane (white arrow)圖1 H.parasuis SC096株野生型及莢膜多糖缺陷型菌株抗巨噬細(xì)胞吞噬試驗(yàn)(間接免疫熒光)Fig.1 Anti-macrophage experimental results of H.parasuis SC096 strains wild-type and capsular polysaccharide-deficient strain (By indirect immunofluorescence assay)
M.PageRulerTM Prestained Protein Ladder SM0671;1.H.parasuis SC096株莢膜多糖;2.H.parasuis SC096株脂多糖M.PageRulerTM Prestained Protein Ladder SM0671;1.Capsular polysaccharide of H.parasuis SC096 strain;2.Lipopolysaccharide of H.parasuis SC096 strain圖2 H.parasuis SC096株莢膜多糖提取結(jié)果Fig.2 Capsular polysaccharide of H.parasuis SC096 strain
2.2.2流式細(xì)胞術(shù)檢測(cè)結(jié)果統(tǒng)計(jì)結(jié)果顯示(表2),野生型菌株組巨噬細(xì)胞總的吞噬率為12.51%,吞入效率為89.61%;莢膜多糖缺陷型組巨噬細(xì)胞總的吞噬率為27.18%,吞入效率為91.06%。加入外源莢膜多糖后,野生型菌株組巨噬細(xì)胞總的吞噬率降為2.72%,吞入效率降為32.72%;莢膜多糖缺陷型組巨噬細(xì)胞總的吞噬率降為3.59%,吞入效率基本不變,為91.36%。加入和外源莢膜多糖等量的細(xì)胞松弛素B后,野生型菌株組總的吞噬率降為5.52%,莢膜多糖缺陷型降為15.59%。
流式細(xì)胞儀雙通道檢測(cè)結(jié)果顯示為4個(gè)區(qū)間,B1對(duì)應(yīng)紅色熒光,B2對(duì)應(yīng)既有紅色熒光又有綠色熒光,B3對(duì)應(yīng)無(wú)熒光,B4對(duì)應(yīng)只有綠色熒光(圖3)。其中,綠色熒光結(jié)果表示H.parasuis帶有的熒光,紅色熒光為吞噬結(jié)束后抗H.parasuis抗體結(jié)合上的熒光。當(dāng)H.parasuis被巨噬細(xì)胞吞噬吞入到細(xì)胞內(nèi)時(shí),則抗體無(wú)法把紅色熒光標(biāo)記到細(xì)菌上,而當(dāng)其被捕獲在巨噬細(xì)胞細(xì)胞膜上,未被完全吞噬進(jìn)去時(shí),抗體可以把紅色熒光結(jié)合到細(xì)菌上。即,只有綠色熒光的細(xì)胞為完全吞入H.parasuis的巨噬細(xì)胞,既有紅光又有綠光的為未完全吞入H.parasuis的巨噬細(xì)胞。
表2流式細(xì)胞術(shù)檢測(cè)H.parasuisSC096株野生型及莢膜多糖缺陷型菌株試驗(yàn)統(tǒng)計(jì)結(jié)果
Table 2Statistical results of anti-macrophage by results ofH.parasuisSC096 strains wild-type and capsular polysaccharide-deficient strain (By flow cytometry)
%
A.野生型組;B.野生型+莢膜多糖組;C.野生型+細(xì)胞松弛素B組;D.莢膜多糖缺陷型組;E.莢膜多糖缺陷型+莢膜多糖組;F.莢膜多糖缺陷型+細(xì)胞松弛素B組A.Wild-type;B.Wild-type +CPS;C.Wild-type +Cytochalasin B;D.Capsular polysaccharide-deficient strain;E.Capsular polysaccharide-deficient strain +CPS;F.Capsular polysaccharide-deficient strain +Cytochalasin B圖3 H.parasuis SC096株野生型及莢膜多糖缺陷型菌株抗巨噬細(xì)胞吞噬試驗(yàn)結(jié)果(流式細(xì)胞術(shù))Fig.3 Anti-macrophage experimental results of H.parasuis SC096 strains wild-type and capsular polysaccharide-deficient strain (By flow cytometry)
莢膜是細(xì)胞壁外包圍的一層黏液性物質(zhì),有黏附、營(yíng)養(yǎng)、抗干燥、抗吞噬及抗有害物質(zhì)損傷等作用,在細(xì)菌的生存中起重要的作用。莢膜的主要成分是多糖和多肽,多糖有助于細(xì)菌躲避宿主的免疫攻擊,在宿主還沒(méi)有產(chǎn)生特異性抗體時(shí),莢膜多糖對(duì)抵抗宿主非特異性免疫攻擊起到關(guān)鍵的作用,它能阻礙補(bǔ)體因子與細(xì)菌表面有效的激活因子接觸,從而阻止膜攻擊復(fù)合體(MAC)對(duì)細(xì)菌的攻擊[7-8]。有些細(xì)菌的莢膜多糖可以抑制巨噬細(xì)胞的細(xì)胞膜脂微區(qū)(lipid microdomains)形成,進(jìn)一步抑制巨噬細(xì)胞的吞噬能力[9],還有細(xì)菌的莢膜多糖可以與宿主細(xì)胞表面蛋白相互作用,抑制細(xì)胞IL-8的釋放[10]。
副豬嗜血桿菌莢膜多糖合成基因座的位置比較保守,但是不同血清型菌株的基因組成相差較大,莢膜多糖的遺傳和結(jié)構(gòu)差異決定了副豬嗜血桿菌血清型具有多樣性[11]。H.parasuis莢膜通常在抵御宿主補(bǔ)體攻擊中具有作用,有研究發(fā)現(xiàn)高抗血清殺傷的H.parasuis菌株SH0165莢膜多糖基因座上的capD基因是關(guān)鍵的毒力因子,capD缺陷會(huì)使SH0165致病能力下降以及對(duì)補(bǔ)體敏感[12]。莢膜結(jié)構(gòu)對(duì)H.parasuis抗巨噬細(xì)胞吞噬也有重要作用,A.Olvera等[4]發(fā)現(xiàn)分離自有全身癥狀豬的H.parasuis,在與PAMs細(xì)胞相互作用后可觀察到有明顯的莢膜,這表明在抗吞噬作用中莢膜表面結(jié)構(gòu)發(fā)揮了一定的作用。研究發(fā)現(xiàn)Wza基因編碼莢膜多糖輸出蛋白[13],敲除Wza基因的突變株表現(xiàn)出對(duì)豬肺泡巨噬細(xì)胞的吞噬作用更加敏感[14]。關(guān)于莢膜多糖抗巨噬細(xì)胞吞噬的原理,在其他細(xì)菌上也有過(guò)報(bào)道,有的細(xì)菌莢膜靠模擬宿主體內(nèi)成分逃避免疫識(shí)別的方法,進(jìn)而逃避巨噬細(xì)胞的吞噬,有的細(xì)菌莢膜多糖可以抑制巨噬細(xì)胞吞噬結(jié)構(gòu)的形成,進(jìn)一步抑制巨噬細(xì)胞的吞噬作用[15-17]。
本研究中作者先采用間接免疫熒光法檢測(cè)了PAMs細(xì)胞對(duì)H.parasuisSC096株及其莢膜多糖缺陷型菌株的吞噬情況,發(fā)現(xiàn)H.parasuisSC096株多存在于PAMs細(xì)胞外,而莢膜多糖缺陷型菌株則主要存在于PAMs細(xì)胞內(nèi),說(shuō)明莢膜多糖缺陷型菌株更易被巨噬細(xì)胞吞噬,其抗吞噬能力較SC096親本株弱。這一結(jié)果表明莢膜多糖缺失后H.parasuis抗巨噬細(xì)胞吞噬能力降低,莢膜多糖在H.parasuis抗巨噬細(xì)胞吞噬過(guò)程中可能起重要作用。
作者還運(yùn)用流式細(xì)胞術(shù)分別統(tǒng)計(jì)了PAMs細(xì)胞對(duì)SC096野生型菌株及其莢膜多糖缺陷型菌株的吞噬數(shù)。數(shù)據(jù)表明無(wú)論是總的吞噬率還是吞入效率,野生型菌株組均小于莢膜多糖缺陷型菌株組,說(shuō)明莢膜多糖缺失后的菌株更易被巨噬細(xì)胞捕捉和吞噬。加入外源莢膜多糖后,野生型菌株組和莢膜多糖缺陷型菌株組的巨噬細(xì)胞吞噬率都有所降低,說(shuō)明外源的莢膜多糖可以降低巨噬細(xì)胞對(duì)H.parasuis的吞噬效率,抑制巨噬細(xì)胞的吞噬能力,但野生型組的PAMs細(xì)胞吞噬率仍遠(yuǎn)低于莢膜多糖缺陷型組,這提示菌體表面的莢膜結(jié)構(gòu)可以抵御巨噬細(xì)胞的吞噬。另外,細(xì)胞松弛素B可以抑制巨噬細(xì)胞形成吞噬結(jié)構(gòu),進(jìn)而抑制其吞噬能力。加入和外源莢膜多糖等量的細(xì)胞松弛素B后,野生型菌株組和莢膜多糖缺陷型菌株組總的吞噬率也有所降低,但降低程度不如外源莢膜多糖。這提示外源性莢膜多糖抑制巨噬細(xì)胞吞噬的能力強(qiáng)于細(xì)胞松弛素B。研究結(jié)果初步解釋了H.parasuisSC096株莢膜多糖抗巨噬細(xì)胞吞噬的機(jī)制,為進(jìn)一步研究副豬嗜血桿菌的致病機(jī)制提供了理論基礎(chǔ)。
比較H.parasuisSC096株野生型和莢膜缺陷型菌株抗豬肺泡巨噬細(xì)胞吞噬的能力,發(fā)現(xiàn)莢膜丟失后H.parasuis抗巨噬細(xì)胞吞噬的能力下降。H.parasuisSC096株莢膜多糖可以明顯抑制巨噬細(xì)胞對(duì)該菌的吞噬能力。
[1]OLIVEIRA S,PIJOAN C.Haemophilusparasuis:new trends on diagnosis,epidemiology and control[J].VetMicrobiol,2004,99(1):1-12.
[2]SOLANO G I,SEGALéS J,COLLINS J E,et al.Porcine reproductive and respiratory syndrome virus (PRRSv) interaction withHaemophilusparasuis[J].VetMicrobiol,1997,55(1-4):247-257.
[3]MOROZUMI T,NICOLET J.Morphological variations ofHaemophilusparasuisstrains[J].JClinMicrobiol,1986,23(1):138-142.
[4]OLVERA A,BALLESTER M,NOFRARIAS M,et al.Differences in phagocytosis susceptibility inHaemophilusparasuisstrains[J].VetRes,2009,40(3):24.
[5]李卓婭,GEMSA D,馮新為.細(xì)胞骨架系統(tǒng)對(duì)TNF-α 產(chǎn)生的影響[J].上海免疫學(xué)雜志,1995,15(5):261-263.
LI Z Y,GEMSA D,F(xiàn)ENG X W.Effect of the cytoskeletal system on TNF-α production[J].ShanghaiJournalofImmunology,1995,15(5):261-263.(in Chinese)
[6]HEISS C,BURTNICK M N,WANG Z,et al.Structural analysis of capsular polysaccharides expressed byBurkholderiamalleiandBurkholderiapseudomallei[J].CarbohydrRes,2012,349:90-94.
[7]FRANK M M,JOINER K,HAMMER C.The function of antibody and complement in the lysis of bacteria[J].RevInfectDis,1987,9(Suppl 5):S537-S545.
[8]HOWARD C J,GLYNN A A.The virulence for mice of strains ofEscherichiacolirelated to the effects of K antigens on their resistance to phagocytosis and killing by complement[J].Immunology,1971,20(5):767-777.
[9]HOUDE M,GOTTSCHALK M,GAGNON F,et al.Streptococcussuiscapsular polysaccharide inhibits phagocytosis through destabilization of lipid microdomains and prevents lactosylceramide-dependent recognition[J].InfectImmun,2012,80(2):506-517.
[10]SHARMA A,QADRI A.Vi polysaccharide ofSalmonellatyphitargets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses[J].ProcNatlAcadSciUSA,2004,101(50):17492-17497.
[11]HOWELL K J,WEINERT L A,LUAN S L,et al.Gene content and diversity of the loci encoding biosynthesis of capsular polysaccharides of the 15 serovar reference strains ofHaemophilusparasuis[J].JBacteriol,2013,195(18):4264-4273.
[12]WANG X,XU X,WU Y,et al.Polysaccharide biosynthesis proteinCapDis a novel pathogenicity-associated determinant ofHaemophilusparasuisinvolved in serum-resistance ability[J].VetMicrobiol,2013,164(1-2):184-189.
[13]曹瑞娟.副豬嗜血桿菌wza基因在其粘附和抗吞噬中的作用研究[D].武漢:華中農(nóng)業(yè)大學(xué),2014.
CAO R J.The research on adhesion and resisting phagocytosis ofwzainHaemophilusparasuis[D].Wuhan:Huazhong Agricultural University,2014.(in Chinese)
[14]康磊,李軍星,王一成,等.副豬嗜血桿菌Wza基因缺失株的構(gòu)建及生物學(xué)特性研究[J].農(nóng)業(yè)生物技術(shù)學(xué)報(bào),2015,23(6):806-815.
KANG L,LI J X,WANG Y C,et al.Construction and biological characteristic ofWza-deficient mutant ofHaemophilusparasuis[J].JournalofAgriculturalBiotechnology,2015,23(6):806-815.(in Chinese)
[15]王斯陽(yáng).肺炎克雷伯桿菌感染小鼠白細(xì)胞IL-10及其mRNA的變化[D].沈陽(yáng):中國(guó)醫(yī)科大學(xué),2012.
WANG S Y.Diversificationin of IL-10 and its mRNA in mice infected withKlebsiellapneumoniae[D].Shenyang:China Medical University,2012.(in Chinese)
[16]李平,譚宏月,胡嬋,等.新生隱球菌GXM的純化及其對(duì)巨噬細(xì)胞甘露糖受體表達(dá)調(diào)節(jié)的研究[J].中國(guó)真菌學(xué)雜志,2012,7(5):265-268.
LI P,TAN H Y,HU C,et al.Purification of capsular polysaccharide GXM fromCryptococcusneoformansand it’s role in regulating MR expression in macrophages[J].ChineseJournalofMycology,2012,7(5):265-268.(in Chinese)
[17]丁丹丹.豬鏈球菌2型cps2E基因缺失株構(gòu)建及生物學(xué)特性研究[D].武漢:華中農(nóng)業(yè)大學(xué),2014.
DING D D.Construction and characterization ofcps2Edeleted mutants ofStreptococcussuisserotype 2[D].Wuhan:Huazhong Agricultural University,2014.(in Chinese)
(編輯白永平)
Role of Capsular Polysaccharide inHaemophilusparasuisSC096 Strain Anti-Porcine Alveolar Macrophage Phagocytosis
ZHOU Qi1,HE Xian-hui1,YANG Qiao-mei2,F(xiàn)ENG Sai-xiang1,F(xiàn)AN Hui-ying1*,LIAO Ming1*
(1.CollegeofVeterinaryMedicine,SouthChinaAgriculturalUniversity,Guangzhou510642,China;2.ShaoyangPolytechnic,Shaoyang422000,China)
The aim of the experiment was to clarify the role of the capsular polysaccharide in anti-porcine alveolar macrophage phagocytosis ofHaemophilusparasuis.The anti-phagocytosis test was conducted by using indirect immunofluorescence method and flow cytometry withH.parasuisSC096 wild-type strain,and capsular deficient strain.The results showed that theH.parasuisSC096 wild-type strains were observed mainly outside the macrophages,while capsular polysaccharide-deficient were observed in macrophages by indirect immunofluorescence experiments.Flow cytometry results showed that the total macrophage phagocytosis rate was 12.51% and swallowed efficiency was 89.61% in the wild-type strain group;the total macrophage phagocytosis rate was 27.18% and swallowed efficiency was 91.06% in the capsular polysaccharide-deficient group.By adding exogenous capsular polysaccharide,total macrophage phagocytosis rate was reduced to 2.72%,swallowed efficiency was reduced to 32.72% in the wild-type strain group;the total macrophage phagocytosis rate dropped to 3.59%,swallowed efficiency was nearly unchanged at 91.36% in the capsular polysaccharide-deficient group.The ability of anti-macrophage phagocytosis ofH.parasuiswas reduced through removing capsular polysaccharide,which demonstrated that capsular polysaccharide may inhibit the ability of macrophage phagocytosis.
Haemophilusparasuis;capsular polysaccharide;porcine alveolar macrophage;phagocytosis
10.11843/j.issn.0366-6964.2016.06.019
2015-10-21
農(nóng)業(yè)部公益性行業(yè)科研專項(xiàng)經(jīng)費(fèi)項(xiàng)目(201303034);農(nóng)業(yè)科研杰出人才及其創(chuàng)新團(tuán)隊(duì)-現(xiàn)代農(nóng)業(yè)人才支撐計(jì)劃項(xiàng)目[農(nóng)財(cái)發(fā)(2012)160號(hào)];教育部博士點(diǎn)基金項(xiàng)目(20114404110016);廣東省"三高"農(nóng)業(yè)專項(xiàng)資金(5500-F15071)
周琪(1991-),女,江西興國(guó)人,碩士生,主要從事動(dòng)物傳染病學(xué)研究,E-mail: 15909348676@163.com
廖明,男,教授,E-mail: mliao@scau.edu.cn; 樊惠英,女,教授,E-mail:hyfan@scau.edu.cn
S852.61
A
0366-6964(2016)06-1232-07